Benefits of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide, versus insulin glargine and lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: The LixiLan-O randomized trial
However, patients with established type 2 diabetes, significant obesity (BMI 35), cardiovascular risk factors, or previous medication trials should have a provider conversation about whether natural approaches alone meet clinical need
Alves E, Binienda Z, Carvalho F, Alves CJ, Fernandes E, de Lourdes BM, Tavares MA, Summavielle T (2009) Acetyl-L-carnitine provides effective in vivo neuroprotection over 3, 4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain
Ngoi ra, Glutathione cn h tr chuyn ha cht bo v cholesterol nhng cht cn thit gi cho gan khe mnh, ci thin qu trnh sn xut mt